Pacira Settles With FDA Over Pain Drug's Off-Label Uses
Pacira Pharmaceuticals Inc. said Tuesday it has settled its recent dispute with the U.S. Food and Drug Administration over the agency's allegedly inappropriate attempt to halt the company's off-label marketing of...To view the full article, register now.
Already a subscriber? Click here to view full article